ARLZ
Aralez Pharmaceuticals Inc.
ARLZ
ARLZ
Delisted
ARLZ was delisted on the 20th of August, 2018.
83 hedge funds and large institutions have $128M invested in Aralez Pharmaceuticals Inc. in 2016 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 29 increasing their positions, 19 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
83
Holders Change
–
Holders Change %
0%
% of All Funds
2.08%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.08%
New
14
Increased
29
Reduced
19
Closed
13
Calls
$666K
Puts
$920K
Net Calls
-$254K
Net Calls Change
+$876K
Top Buyers
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.97M |
| 2 |
AC
Armistice Capital
New York
|
+$3.25M |
| 3 |
BC
Broadfin Capital
New York
|
+$1.7M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$557K |
| 5 |
Morgan Stanley
New York
|
+$509K |
Top Sellers
| 1 |
VOAM
Vertex One Asset Management
Vancouver,
British Columbia, Canada
|
-$1.57M |
| 2 |
KAM
Kavi Asset Management
New York
|
-$1.52M |
| 3 |
D.E. Shaw & Co
New York
|
-$1.25M |
| 4 |
Millennium Management
New York
|
-$1.08M |
| 5 |
AA
Ancora Advisors
Cleveland,
Ohio
|
-$589K |
